1. Short Time Delay Between Previous Prostate Biopsy for Prostate Cancer Assessment and Holmium Laser Enucleation of the Prostate Correlates with Worse Perioperative Outcomes
- Author
-
Daniele Romagnoli, Carlo Casablanca, E. Balestrazzi, Rita Golfieri, Giuseppe Rosiello, Riccardo Schiavina, Caterina Gaudiano, C. Beretta, Marco Amato, Pietro Piazza, Stefano Puliatti, Alexandre Mottrie, A. Ercolino, Lorenzo Bianchi, Marco Giampaoli, Matteo Droghetti, Dario Recenti, Daniele D'Agostino, Angelo Porreca, Piazza P., Bianchi L., Giampaoli M., Droghetti M., Casablanca C., Ercolino A., Beretta C., Recenti D., Balestrazzi E., Puliatti S., Rosiello G., Amato M., Romagnoli D., D'Agostino D., Gaudiano C., Golfieri R., Porreca A., Mottrie A., and Schiavina R.
- Subjects
Male ,medicine.medical_specialty ,Prostate biopsy ,Urology ,Biopsy ,Enucleation ,030232 urology & nephrology ,Prostatic Hyperplasia ,Lasers, Solid-State ,03 medical and health sciences ,Prostate cancer ,Holmium ,0302 clinical medicine ,Prostate ,Lower urinary tract symptoms ,medicine ,Lower urinary tract symptom ,Humans ,Intraoperative Complications ,Retrospective Studies ,Benign prostatic hyperplasia ,medicine.diagnostic_test ,business.industry ,Prostatic Neoplasms ,Odds ratio ,Perioperative ,medicine.disease ,Confidence interval ,medicine.anatomical_structure ,Treatment Outcome ,Holmium laser enucleation of the prostate ,030220 oncology & carcinogenesis ,business - Abstract
Background No data are available regarding the impact of time between a previous transrectal prostate biopsy (PB) and holmium laser enucleation of the prostate (HoLEP) on perioperative outcomes. Objective To evaluate the impact of time from PB to HoLEP on perioperative outcomes. Design, setting, and participants A total of 172 consecutive patients treated with HoLEP within 12 mo of a single previous transrectal PB at two tertiary centers were included. Outcome measurements and statistical analysis Patients were stratified into two groups according to the median time from PB to HoLEP (namely, ≤6 and >6 mo). The primary outcome was intraoperative complications. Multivariate logistic regressions were used to identify the predictors of intraoperative complications. Linear regressions were used to test the association between the time from PB to HoLEP and intraoperative complications, enucleation efficiency, and enucleation time. Results and limitations In total, 93 (54%) and 79 (46%) patients had PB ≤ 6 and >6 mo before HoLEP, respectively. Patients in PB ≤ 6 mo group experienced higher rates of intraoperative complications than those in PB > 6 mo group (14% vs 2.6%, p = 0.04). At multivariable analysis, time between PB and HoLEP was an independent predictor of intraoperative complications (odds ratio: 0.74; 95% confidence interval: 0.6–0.9; p = 0.006). Finally, the risk of intraoperative complications reduced by 1.5%, efficiency of enucleation increased by 4.1%, and enucleation time reduced by 1.7 min for each month passed from PB to HoLEP (all p ≤ 0.006). Selection of patients with only one previous PB represents the main limitation. Conclusions The time from PB to HoLEP of ≤6 mo is associated with a higher risk of intraoperative complications, lower enucleation efficacy, and longer enucleation time. Patient summary Patients with a prostate biopsy (PB) ≤6 mo before holmium laser enucleation of the prostate (HoLEP) had significantly worse outcomes than those with a PB > 6 mo before HoLEP.
- Published
- 2021